ArticleLiver cancer2025

Conversion Surgery after Immune Checkpoint Inhibitor-Based Combination Therapy for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study.

Mingjian Piao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.